Envoy Medical announces up to $16M registered direct offering and warrant sale

Envoy Medical, Inc.

Offering includes 3,007,524 shares at $1.33/share for ~$4M upfront; warrants for 9,022,572 shares at $1.33.
Warrants expire 24 months after registration effective date; potential gross proceeds total up to $16M if exercised.
H.C. Wainwright & Co. acts as exclusive placement agent with 7.5% cash fee plus 1.0% management fee.
Expected closing on October 9, 2025; net proceeds for working capital and general corporate purposes.
Placement agent receives warrants for 225,564 shares at $1.6625 per share, expiring October 2030.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.